3 results
Not approvedWill not start
To determine the prevalence and severity of ASA-related allergic reaction in SM patients.
Approved WMOPending
To determine the prevalence and severity of aspirin-related allergic reactions in SM patients.
Approved WMORecruiting
Part A: Safety:• To characterize the safety and tolerability of up to four dose levels of rilzabrutinibin patients with ITPEfficacy:• To explore the clinical activity of up to four dose levels of rilzabrutinibin relapsed/refractory patients with ITP…